Ana García Cerdeño

Ana García Cerdeño has a diverse work experience in the field of scientific research. Ana is currently working as an R+D Scientist at BioSystems since March 2022. Before this role, they worked at Lipotrue from January 2017 to February 2022 as an R&D Project Researcher. At Lipotrue, they conducted studies on the toxicity and efficacy of new active ingredients in the cosmetic industry. Ana'sresponsibilities included maintaining human skin cell cultures, performing experiments involving various cell culture techniques, and conducting assays and analyses related to cell viability and toxicity.

Prior to their role at Lipotrue, Ana worked as a Research Intern at Vall d'Hebron Institute of Oncology (VHIO) from January 2016 to June 2016. In this position, they conducted research for their Master Thesis Project on the mechanism of action of an anti-tumorigenic compound in glioblastoma. Ana'sduties included maintaining human glioblastoma cell cultures and conducting molecular biology techniques such as western blot, DNA extraction, immunocytochemistry, and flow cytometry.

Additionally, Ana has experience as a Research Intern at Vall d'Hebron Institute of Research (VHIR) from July 2014 to September 2014.

Overall, Ana García Cerdeño has a strong background in scientific research, with expertise in cell culture techniques, molecular biology, and various assays and analyses related to efficacy and toxicity in the cosmetic and oncology industries.

Ana García Cerdeño has a Bachelor's degree (BSc) in Biotechnology from Universitat Autònoma de Barcelona, which they obtained in the years 2011 to 2015. Ana later pursued a Master of Science (MS) in Translational Medicine from Universitat de Barcelona, which they completed in the years 2015 to 2016. In addition to their degrees, Ana also holds a certification in First Certificate in English (FCE) from the University of Cambridge, although the specific month and year of attainment are not provided.